Characterizing Gabapentinoid Use Among Patients With Isolated Low Back Pain.
Gwyneth C MaloyScott J HalperinPhilip P RatnasamyJonathan Newman GrauerPublished in: Global spine journal (2024)
Of nearly 1.2 million patients with isolated LBP, 14.2% were prescribed gabapentinoids within one year of their LBP diagnosis. Patient characteristics predictive of receiving gabapentinoids were predominantly non-clinical factors.
Keyphrases